Aileron Therapeutics Inc (NASDAQ:ALRN)
| 0.3003 BATS BZX Real-Time Price As of 3:53pm ET |  -0.1189 / -28.36%Today’s Change | 0.27 Today|||52-Week Range 1.34 | -46.65% Year-to-Date |
Latest ALRN News | Press Releases
No recent news for Aileron Therapeutics Inc.
Today’s Trading
| Previous close | 0.42 |
| Today’s open | 0.34 |
| Day’s range | 0.27 - 0.34 |
| Volume | 107,359 |
| Average volume (3 months) | 322,523 |
| Market cap | $36.0M |
Data as of 3:53pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | +51.45% |
| Earnings growth (this year) | -30.17% |
| Earnings growth (next 5 years) | +2.06% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Newron Pharmaceutica... | 0.00 | 0.00% |
| AMPEAmpio Pharmaceutical... | +0.01 | +6.29% |
| AGTCApplied Genetic Tech... | -0.00 | -0.11% |
| OCUPOcuphire Pharma Inc | -0.05 | -2.55% |
Data as of 3:53pm ET, 06/29/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$26.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
